Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase

por Garscha, Ulrike, Romp, Erik, Pace, Simona, Rossi, Antonietta, Temml, Veronika, Schuster, Daniela, König, Stefanie, Gerstmeier, Jana, Liening, Stefanie, Werner, Markus, Atze, Heiner, Wittmann, Sandra, Weinigel, Christina, Rummler, Silke, Scriba, Gerhard K., Sautebin, Lidia, Werz, Oliver
Publicado 2017

Global testing of a consensus solubility assessment to enhance robustness of the WHO biopharmaceutical classification system

por Gigante, Valeria, Pauletti, Giovanni M., Kopp, Sabine, Xu, Minghze, Gonzalez-Alvarez, Isabel, Merino, Virginia, McIntosh, Michelle P., Wessels, Anita, Lee, Beom-Jin, Rezende, Kênnia Rocha, Scriba, Gerhard K.E., Jadaun, Gaurav P.S., Bermejo, Marival
Publicado 2020